4-Methylmorpholine → ethyl 4-((2'-chloro-4',4'-difluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl)methyl)-1-(3-chloro-2-pyridyl)-1H-pyrazole-3-carboxylate

HRID 1517622ノート

反応式

HRID 1517622 の反応式
Cl.[Cl:2][C:3]1[S:18][C:6]2[C:7]3([CH2:17][CH2:16][NH:15][CH2:14][CH2:13]3)[O:8][CH2:9][C:10]([F:12])([F:11])[C:5]=2[CH:4]=1.[Cl:19][C:20]1[C:21]([N:26]2[CH:30]=[C:29]([CH:31]=O)[C:28]([C:33]([O:35][CH2:36][CH3:37])=[O:34])=[N:27]2)=[N:22][CH:23]=[CH:24][CH:25]=1.CN1CCOCC1.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>ClCCCl>[Cl:2][C:3]1[S:18][C:6]2[C:7]3([CH2:13][CH2:14][N:15]([CH2:31][C:29]4[C:28]([C:33]([O:35][CH2:36][CH3:37])=[O:34])=[N:27][N:26]([C:21]5[C:20]([Cl:19])=[CH:25][CH:24]=[CH:23][N:22]=5)[CH:30]=4)[CH2:16][CH2:17]3)[O:8][CH2:9][C:10]([F:12])([F:11])[C:5]=2[CH:4]=1

参加物

6

反応物 4

HCID 79724-MethylmorpholineHCID 5049666Sodium triacetoxyborohydrideHCID 671676842'-Chloro-4',4'-difluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] hydrochlorideHCID 86653546Ethyl 1-(3-Chloro-2-pyridyl)-4-formyl-pyrazole-3-carboxylate

生成物 1

HCID 67168527ethyl 4-((2'-chloro-4',4'-difluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl)methyl)-1-(3-chloro-2-pyridyl)-1H-pyrazole-3-carboxylate収率 73.6%

試薬・触媒・溶媒 1

HCID 111,2-Dichloroethane溶媒

実験手順

To a solution of 2′-chloro-4′,4′-difluoro-4′,5′-dihydrospiro[piperidine-4,7′-thieno[2,3-c]pyran]hydrochloride (0.35 g, 1.1 mmol) and ethyl 1-(3-chloropyridin-2-yl)-4-formyl-pyrazole-3-carboxylate (0.3 g, 1.0 mmol) in 1,2-dichloroethane (20 mL) is added N-methyl morpholine (0.33 g, 3.2 mmol) and molecular sieves (0.10 g). The reaction mixture is stirred at room temperature for 1 h. Sodium triacetoxyborohydride (0.58 g, 2.7 mmol) is added and stirred at room temperature for 16 h. After completion, the reaction mixture is filtered through celite and partitioned between dichloromethane (15 mL) and water (15 mL). The aqueous phase is extracted with dichloromethane (3×30 mL) and the combined organic extracts are dried over sodium sulfate and concentrated in vacuo. The crude mixture is purified by column chromatography over silica gel eluting with dichloromethane/methanol (98:2) to yield 0.4 g (67%) of ethyl 4-((2′-chloro-4′,4′-difluoro-4′,5′-dihydrospiro[piperidine-4,7′-thieno[2,3-c]pyran]-1-yl)methyl)-1-(3-chloro-2-pyridyl)-1H-pyrazole-3-carboxylate. MS (m/z): 543 (M+1).

後処理

  1. stirringstirred at room temperature for 16 h
  2. filtrationAfter completion, the reaction mixture is filtered through celite
  3. custompartitioned between dichloromethane (15 mL) and water (15 mL)
  4. extractionThe aqueous phase is extracted with dichloromethane (3×30 mL)
  5. dry with materialthe combined organic extracts are dried over sodium sulfate
  6. concentrationconcentrated in vacuo
  7. customThe crude mixture is purified by column chromatography over silica gel eluting with dichloromethane/methanol (98:2)

出典と根拠

ORDレコード
ord-ec5c399af7844c35bb59011ed8683d84
出典データセット
uspto-grants-2012_07
特許番号
US08232289B2

反応ノート

読み込み中…